Wilbanks Smith & Thomas Asset Management’s CRISPR Therapeutics CRSP Stock Holding History

Wilbanks Smith & Thomas Asset Management’s Portfolio CRSP Stock Details CRSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell
2022 Q3	$333K	Buy
2022 Q2	$272K	Hold
2022 Q1	$235K	Buy
2021 Q4	$214K	Sell
2021 Q3	$7.79M	Buy
2021 Q2	$400K	Buy
2021 Q1	$244K	Hold
2020 Q4	$306K	Buy